scPharmaceuticals Inc. (2SX.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 04:16PM CEST. Market open.
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 149.84M |
| Enterprise Value | 116.68M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 13.19 |
| Price/Book (mrq) | 4.51 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -6.57 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.09 |
| 52-Week Change 3 | -59.63% |
| S&P500 52-Week Change 3 | 26.27% |
| 52 Week High 3 | 10.9000 |
| 52 Week Low 3 | 4.0000 |
| 50-Day Moving Average 3 | 4.6144 |
| 200-Day Moving Average 3 | 5.3945 |
Share Statistics
| Avg Vol (3 month) 3 | N/A |
| Avg Vol (10 day) 3 | N/A |
| Shares Outstanding 5 | 36.05M |
| Implied Shares Outstanding 6 | 37.01M |
| Float 8 | 16.47M |
| % Held by Insiders 1 | 11.65% |
| % Held by Institutions 1 | 76.28% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -250.28% |
Management Effectiveness
| Return on Assets (ttm) | -31.67% |
| Return on Equity (ttm) | -99.97% |
Income Statement
| Revenue (ttm) | 13.59M |
| Revenue Per Share (ttm) | 0.35 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -55.37M |
| Net Income Avi to Common (ttm) | -54.81M |
| Diluted EPS (ttm) | -1.3200 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 76.99M |
| Total Cash Per Share (mrq) | 2.13 |
| Total Debt (mrq) | 40.27M |
| Total Debt/Equity (mrq) | 108.20% |
| Current Ratio (mrq) | 7.08 |
| Book Value Per Share (mrq) | 1.03 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -59.24M |
| Levered Free Cash Flow (ttm) | -40.4M |
© 2024 Yahoo. All rights reserved.